biote Corp. (BTMD) director receives 130,000 stock options at $2.34 strike

Rhea-AI Filing Summary

biote Corp. director Bret Christensen received a grant of stock options, giving him the right to buy 130,000 shares of Class A Common Stock. The options have an exercise price of $2.34 per share and expire on June 7, 2036.

All 130,000 option shares will vest on the earlier of June 8, 2027 or the day before biote Corp.'s 2027 Annual Meeting of Stockholders, as long as Christensen remains in continuous service through that vesting date.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Christensen Bret

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	130,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy) — 130,000 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 130,000 options Exercise price: $2.34 per share Underlying shares: 130,000 shares +3 more

6 metrics

Options granted 130,000 options Stock Option (Right to Buy) for Class A Common Stock

Exercise price $2.34 per share Exercise price of option grant

Underlying shares 130,000 shares Class A Common Stock underlying the options

Expiration date June 7, 2036 Option expiration date

Vesting date trigger Earlier of June 8, 2027 or day before 2027 Annual Meeting Vesting condition subject to continuous service

Shares following transaction 130,000 derivative securities Total options held after this grant

Key Terms

Stock Option (Right to Buy), Class A Common Stock, Annual Meeting of Stockholders, continuous service, +1 more

5 terms

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Class A Common Stock financial

"underlying_security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Annual Meeting of Stockholders financial

"the Issuer's 2027 Annual Meeting of Stockholders"

continuous service financial

"subject to the Reporting Person's continuous service through such vesting date"

vesting financial

"All shares subject to the option award shall vest on the earlier of June 8, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Christensen Bret

(Last) (First) (Middle)

C/O BIOTE CORP.

1875 W. WALNUT HILL LN #100

(Street)

IRVING TEXAS 75038

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
biote Corp. [ BTMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$2.34	06/08/2026		A		130,000		(1)	06/07/2036	Class A Common Stock	130,000	$0.00	130,000	D

Explanation of Responses:

1. All shares subject to the option award shall vest on the earlier of June 8, 2027 or the day prior to the date of the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuous service through such vesting date.

Remarks:

	/s/ Kendal McNeely, as Attorney-in-Fact for Bret Christensen	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did biote Corp. (BTMD) report for Bret Christensen?

biote Corp. reported that director Bret Christensen received a grant of stock options for 130,000 shares. These options give him the right to buy Class A Common Stock at a fixed price as part of his equity compensation package.

How many biote Corp. (BTMD) options were granted to Bret Christensen?

Bret Christensen was granted stock options covering 130,000 shares of biote Corp. Class A Common Stock. This derivative award represents a compensation-related equity incentive, rather than an open-market purchase or sale of existing shares.

What is the exercise price of Bret Christensen’s biote Corp. (BTMD) options?

The exercise price of Bret Christensen’s options is $2.34 per share. This means he can buy up to 130,000 shares of Class A Common Stock at $2.34 if and when the options vest and are exercised.

When do Bret Christensen’s biote Corp. (BTMD) options vest?

All shares under Bret Christensen’s option award vest on the earlier of June 8, 2027 or the day before biote Corp.’s 2027 Annual Meeting of Stockholders, assuming he maintains continuous service through that vesting date.

When do Bret Christensen’s biote Corp. (BTMD) options expire?

Bret Christensen’s stock options expire on June 7, 2036. After that expiration date, any unexercised portion of the 130,000-share option grant will no longer be exercisable, ending his right to purchase shares under this award.

Is Bret Christensen’s biote Corp. (BTMD) Form 4 transaction a market buy or sell?

The Form 4 shows a grant of stock options coded as an acquisition (A), not a market buy or sell. It is a compensation-related award providing potential future share purchases, rather than an immediate open-market transaction.